154 related articles for article (PubMed ID: 9816012)
21. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
Wijffels KI; Marres HA; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH
Oral Oncol; 2008 Apr; 44(4):335-44. PubMed ID: 17689286
[TBL] [Abstract][Full Text] [Related]
22. Labelling indices in human tumours: to apply corrections or not--that is the question.
Bergström C; Begg A; Palmqvist R; Waites A; Denekamp J
Br J Cancer; 1999 Jul; 80(10):1635-43. PubMed ID: 10408411
[TBL] [Abstract][Full Text] [Related]
23. [Determination of potential doubling time using in vitro continuous labeling method with bromodeoxyuridine: estimation in head and neck squamous cell carcinoma].
Mariya Y; Aoki M; Tarusawa N; Takekawa S; Kaimori M; Abe Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):976-8. PubMed ID: 8371947
[TBL] [Abstract][Full Text] [Related]
24. Measurement of the proliferative activity of three different sublines of the Dunning rat prostate tumor R3327.
Lohr F; Wenz F; Flentje M; Peschke P; Hahn EW
Strahlenther Onkol; 1993 Jul; 169(7):438-45. PubMed ID: 8342118
[TBL] [Abstract][Full Text] [Related]
25. Cell-kinetical analyses of squamous cell carcinomas of the oral region and the effect of a combined therapy of 5 fluorouracil and irradiation. A contribution to the discussion about tumorcell-synchronization.
Helpap B; Herberhold C; Thelen M; Stiens R; Koch U
Strahlentherapie; 1977 Nov; 153(11):774-80. PubMed ID: 73240
[TBL] [Abstract][Full Text] [Related]
26. Modulation of tumor cell proliferation and apoptosis by polyamine depletion in cells of head and neck squamous cell carcinomas.
Bock JM; Pickart MA; Pink JJ; Harari PM
Radiat Res; 1999 Dec; 152(6):604-10. PubMed ID: 10581530
[TBL] [Abstract][Full Text] [Related]
27. Allelic loss and tumor pathology in head and neck squamous cell carcinoma.
Rybicki BA; Savera AT; Gomez JA; Patel SC; Ballard NE; Benninger MS; Zarbo RJ; Van Dyke DL
Mod Pathol; 2003 Oct; 16(10):970-9. PubMed ID: 14559979
[TBL] [Abstract][Full Text] [Related]
28. Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.
Myers JN; Yasumura S; Suminami Y; Hirabayashi H; Lin Wc; Johnson JT; Lotze MT; Whiteside TL
Clin Cancer Res; 1996 Jan; 2(1):127-35. PubMed ID: 9816099
[TBL] [Abstract][Full Text] [Related]
29. Cell cycle kinetics in normal human skin by in vivo administration of iododeoxyuridine and application of a differentiation marker--implications for cell cycle kinetics in psoriatic skin.
van Erp PE; Boezeman JB; Brons PP
Anal Cell Pathol; 1996 Jun; 11(1):43-54. PubMed ID: 8844104
[TBL] [Abstract][Full Text] [Related]
30. Use of 1,2:5,6-dianhydrogalactitol in studies on cell kinetics-directed chemotherapy schedules in human tumors in vivo.
Barranco SC; Townsend CM; Costanzi JJ; May JT; Baltz R; O'Quinn AG; Leipzig B; Hokanson KM; Guseman LF; Boerwinkle WR
Cancer Res; 1982 Jul; 42(7):2899-2905. PubMed ID: 7083178
[TBL] [Abstract][Full Text] [Related]
31. Variability of the thymidine labeling index in squamous cell carcinoma of the head and neck.
Greenberg B; Woo L; Blatchford S; Aguirre M; Garewal H
Laryngoscope; 1988 Jun; 98(6 Pt 1):668-70. PubMed ID: 3374244
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
Sauter ER; Nesbit M; Watson JC; Klein-Szanto A; Litwin S; Herlyn M
Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer.
Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
Neoplasma; 2005; 52(3):199-207. PubMed ID: 15875080
[TBL] [Abstract][Full Text] [Related]
34. Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine.
Raza A; Alvi S; Broady-Robinson L; Showel M; Cartlidge J; Mundle SD; Shetty VT; Borok RZ; Dar SE; Chopra HK; Span L; Parcharidou A; Hines C; Gezer S; Venugopal P; Loew J; Showel J; Alston D; Hernandez B; Rifkin S; Robin E; Shah R; Gregory SA
Exp Hematol; 1997 Jun; 25(6):530-5. PubMed ID: 9197332
[TBL] [Abstract][Full Text] [Related]
35. [A cell kinetic study of human central nervous system tumors with 5-bromodeoxyuridine (BrdU)].
Nagashima T; Hoshino T
No To Shinkei; 1985 Dec; 37(12):1195-201. PubMed ID: 3912000
[TBL] [Abstract][Full Text] [Related]
36. Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model.
Sauter ER; Herlyn M; Liu SC; Litwin S; Ridge JA
Clin Cancer Res; 2000 Feb; 6(2):654-60. PubMed ID: 10690551
[TBL] [Abstract][Full Text] [Related]
37. Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.
Börjesson PK; Postema EJ; Roos JC; Colnot DR; Marres HA; van Schie MH; Stehle G; de Bree R; Snow GB; Oyen WJ; van Dongen GA
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3961S-72S. PubMed ID: 14506195
[TBL] [Abstract][Full Text] [Related]
38. Metallothionein immunoreactivity in head and neck carcinomas; special reference to clinical behaviors and chemotherapy responses.
Muramatsu Y; Hasegawa Y; Fukano H; Ogawa T; Namuba M; Mouri K; Fujimoto Y; Matsuura H; Takai Y; Mori M
Anticancer Res; 2000; 20(1A):257-64. PubMed ID: 10769664
[TBL] [Abstract][Full Text] [Related]
39. [Cell proliferation in human cerebral tumors. In vivo study of 45 cases by incorporation of 5-iododesoxyuridine].
Duprez A; Barat JL; Girard A; Hoffmann M; Hepner H
Neurochirurgie; 1990; 36(3):157-66. PubMed ID: 2234259
[TBL] [Abstract][Full Text] [Related]
40. 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.
Ricker JL; Chen Z; Yang XP; Pribluda VS; Swartz GM; Van Waes C
Clin Cancer Res; 2004 Dec; 10(24):8665-73. PubMed ID: 15623651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
